mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.1 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.1 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.1 |